Article

Sightpath Medical to offer Alcon’s Centurion

Sightpath Medical has announced that it will offer Alcon Laboratory’s Centurion Vision System as an option in their cataract surgery suite of equipment and services.

 

Bloomington, MN-Sightpath Medical has announced that it will offer Alcon Laboratories’ Centurion Vision System as an option in their cataract surgery suite of equipment and services.

Transported via Sightpath Medical’s air-ride and climate controlled vehicle, the phacoemulsification system will be accompanied by a certified surgical technician.

Rollout will begin in late 2013 in the upper Midwest, with nationwide access available in 2014.

“For the past two decades, Sightpath Medical has maintained a rich tradition of anticipating trends in the industry and accommodating surgeon preferences across vendor lines,” said Dan Robins, senior vice president of operation, Sightpath Medical. “Including the Centurion in our offering, so soon after its release, further ensures we are able to deliver on our promise to provide access to the most advanced technology on the market, regardless of location.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.